Telix Gross Profit from 2010 to 2025
| TLX Stock | 17.79 0.26 1.48% |
Gross Profit | First Reported 2011-06-30 | Previous Quarter 1.6 M | Current Value 954.1 K | Quarterly Volatility 2.9 M |
Check Telix Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.9 M, Interest Expense of 38.3 M or Selling General Administrative of 123.5 M, as well as many indicators such as Price To Sales Ratio of 8.16, Days Sales Outstanding of 70.39 or Average Payables of 1.8 M. Telix financial statements analysis is a perfect complement when working with Telix Pharmaceuticals Valuation or Volatility modules.
Telix | Gross Profit |
Latest Telix Pharmaceuticals' Gross Profit Growth Pattern
Below is the plot of the Gross Profit of Telix Pharmaceuticals Limited over the last few years. Gross profit is a required income statement account that reflects total revenue of Telix Pharmaceuticals Limited minus its cost of goods sold. It is profit before Telix Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Telix Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Telix Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 405.35 M | 10 Years Trend |
|
Gross Profit |
| Timeline |
Telix Gross Profit Regression Statistics
| Arithmetic Mean | 90,176,079 | |
| Coefficient Of Variation | 207.49 | |
| Mean Deviation | 136,619,198 | |
| Median | 5,660,800 | |
| Standard Deviation | 187,110,426 | |
| Sample Variance | 35010.3T | |
| Range | 557.2M | |
| R-Value | 0.72 | |
| Mean Square Error | 17906T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | 28,412,463 | |
| Total Sum of Squares | 525154.7T |
Telix Gross Profit History
Other Fundumenentals of Telix Pharmaceuticals
Telix Pharmaceuticals Gross Profit component correlations
Click cells to compare fundamentals
About Telix Pharmaceuticals Financial Statements
Telix Pharmaceuticals investors use historical fundamental indicators, such as Telix Pharmaceuticals' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Telix Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 509.7 M | 535.2 M | |
| Gross Profit Margin | 0.65 | 0.68 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.